Helped by TSMC and Foxconn, BioNTech vaccines finally reach Taiwan By Reuters

© Reuters. FILE PHOTO: Vials of the Pfizer-BioNTech vaccine are pictured in a vaccination centre in Geneva, Switzerland, February 3, 2021. REUTERS/Denis Balibouse


By Ann Wang

TAOYUAN, Taiwan (Reuters) -The first batch of BioNTech SE (NASDAQ:)’s COVID-19 vaccine arrived in Taiwan on Thursday, helped by the involvement of two of the world’s most important tech firms after months of heated political and diplomatic wrangling. Taiwan has blamed China, which claims the island as its own territory, for nixing an original order from the German firm this year – charges Beijing has angrily denied. Taiwan’s government then allowed major Apple Inc (NASDAQ:) supplier Foxconn – formally Hon Hai Precision Industry Co Ltd – as well as its high-profile billionaire founder, Terry Gou, along with Taiwan Semiconductor Manufacturing Co Ltd, to negotiate on its behalf for the doses. A $350 million deal for 10 million shots was inked in July, which will be donated to the government for distribution.

A cargo flight from Luxembourg carrying the vaccines landed at Taiwan’s main international airport at Taoyuan, outside of Taipei, at 7 a.m. (2300 GMT), and was met on the tarmac by Health Minister Chen Shih-chung and Sophie Chang, the TSMC Charity Foundation’s chairwoman and Gou’s cousin.

Chen spoke briefly to thank the companies, and a Taiwanese Buddhist group that has also ordered 5 million doses, for their efforts to get the vaccine.

“They’ve worked very hard and overcome all the difficulties,” he said.

Chen did not mention Shanghai Fosun Pharmaceutical, which has the right to sell the shots on BioNTech’s behalf in China, Hong Kong, Macau and Taiwan and whose unit signed the deal for the island’s doses.

A large label on the side of one of the crates with the names of BioNTech, Fosun and the vaccine, using simplified Chinese characters, which are not used in Taiwan, was removed before arrival.

Fosun had posted a picture on its Weibo (NASDAQ:) account of the crate in the warehouse, with the label, before it was loaded onto the aircraft.

In another flourish of drama, China announced the exact arrival date of the vaccines on Wednesday, shortly before Chen began his daily news briefing.

The roughly 900,000 doses of the vaccine, jointly developed with Pfizer Inc (NYSE:), are expected to start being administered later this month.

Taiwan is getting the shots earlier than expected as a delay in regulatory approval of the shot for use in mainland China made a surplus available for the island. The vaccine is approved for use in Chinese-run Hong Kong and Macau. While a relatively small domestic coronavirus outbreak is well under control in Taiwan, only around 5% of its 23.5 million people are fully vaccinated, though the government has millions of vaccines on order. More than 10 million vaccine doses have arrived in Taiwan to date, split between Moderna (NASDAQ:) Inc and AstraZeneca (NASDAQ:) Plc, while local developer Medigen Vaccine Biologics Corp’s shots have also started to be administered.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Source link

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button